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Abstract
Snake envenomization is a neglected public health issue that effects large portions of
the world, as venomous snakes are found on six continents (World Health
Organization,2007). With 2-3 million people bitten globally every year leading to an
estimated 125,000 deaths and 400,000 amputations, researching effective treatments is
important. Several Mammalian species have a natural resistance to snake venom
(Voss, R.S et al.,2012; Bastos, V.A. et al.,2016). The North American Opossum (D.
virginiana) produces proteins that inhibit certain snake venom components including
snake venom metalloproteinases (SVMPs) and phospholipase 2As (PLA2s) (Catanese,
J.J. et al.,1992; Perales, J. et al.,1994; Farah, M.D.F.L. et al.,1996; Neves-Ferreira,
A.G. et al.,2000; Jurgilas, P.I.B. et al.,2003). The goal of studying the protein inhibitors
produced by the North American Opossum is to better understand the mechanisms that
cause inhibition thus leading to the development of effective inhibitors. Eight plasmid
expression vectors containing 6-histidine tags and maltose binding proteins (MBP), the
coding sequence for either DM43 (a SVMPI) or DM64 (aPLA2 inhibitor), and a Tobacco
etch virus (TEV) cleavage site were constructed through Gibson Assembly. Four
constructs were used to produced either MBP-DM43 or MBP-DM64 in E. coli. The
optimization of the enzymatic cleavage reaction between TEV and a model fusion
protein with a TEV cleavage sites, MBP-NusG, was accomplished using 2 experiments.
These experiments optimized the duration, temperature, and amount of TEV used to
conduct the cleavage reaction. For our purposes, the optimal conditions include the
shortest duration and lowest temperature in which the reaction proceeds to completion.
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Reactions conducted at 4°C with 5.5ug TEV for 1hr gave optimal cleavage of MBPNusG providing useful conditions for future reactions.

Background
Snake envenomization is an ever-present public health problem, effecting mainly the
tropical and subtropical regions of the world with venomous snakes on every continent
except Antarctica (Gutiérrez, J.M.; Calvete, J.J. et al.,2017; World Health
Organization,2007). In 2007, the World Health Organization (WHO) classified snake
envenomization as a neglected public health issue. The issue is considered “neglected”
because snake envenomization is a public health problem that tends to effect poor, rural
areas. Although the damage that snake envenomization causes in communities can be
extreme, the problem is often overlooked by public health officials and public health
programs (World Health Organization,2007). Approximately 2-3 million people are bitten
by poisonous snakes every year with an estimated 400,000 amputations and 125,000
fatalities. Although estimations are available, the global epidemiological data is limited.
The main snakes responsible for the 2-3 million envenomizations are rattlesnakes
(genus Crotalus) in North and Central America, saw-scaled vipers (genus Echis) in
Africa, cobras (genus Naja) in Asia, and Kraits (genus Bungarus) in Asia (Warrell,
D.A.,2010). The physical effects of snake venom include local swelling, hemorrhaging,
necrosis, muscle toxicity, and blood toxicity which leads to cardiovascular shock and
kidney failure. Two components of snake venom are responsible for the harmful effect
on the body 1) snake venom metalloproteinases (SVMPs), 2) phospholipases (PLAs).
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These components cause significant damage to surrounding tissues and blood vessels
(World Health Organization, 2010; Gutiérrez J.M.; León, G. et al.,2003).
Anti-venoms are commonly used to treat effected areas after a venous snake bite. Antivenoms are an antibody-based treatment that for the last century have been the only
effective treatment for the systematic effects of snake venom (World Health
Organization, 2010; Gutiérrez J.M.; León, G. et al.,2003). Although antibody-based antivenoms are an effective treatment for snake bites, anti-venom therapies have three
main limitations 1) short or limited self-life, 2) a high cost of production, and 3) limited in
use by being species specific (Gutiérrez, J.M.; Calvete, J.J. et al.,2017). Antibody-based
anti-venoms have to be quickly administered after envenomization to be effective or the
antibody-based anti-venoms won’t prevent irreversible tissue damage caused by
SVMPs and PLAs (Gutiérrez, J.M.; Calvete, J.J. et al.,2017).
A variety of mammalian species, including North American Opossums (D. Virginiana)
have a natural resistance to snake venom (Voss, R.S. et al., 2012; Bastos, V.A. et
al.,2016). Opossums found in both North and South America produce unique proteins
that reduce or prevent the harmful effects of both SVMPs and PLAs (Catanese, J.J. et
al.,1992; Perales, J. et al.,1994; Farah, M.D.F.L. et al.,1996; Neves-Ferreira, A.G. et
al.,2000; Jurgilas, P.I.B. et al.,2003). The Werner laboratory’s overall goal is to
investigate non-antibody-based therapies for the treatment of venomous snake bites.
These non-antibody-based therapies will mimic the natural resistance to snake venom
seen in the North American Opossum and other mammals. It has been suggested that a
mixture of SVMP inhibitors and PLA inhibitors, whether they are small molecules,
peptidomimetics, or intact proteins, could be effective treatment for tissue damage
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caused by snake venom (Lewin, M. et al.,2016; O’Brien, J. et al.,2016; Azofeifa, K. et
al.,2008; Rucavado, A. et al.,2000). These therapies provided an onsite treatment for
snake bites that can be immediately administered with a medical device similar to an
Epi-pen that delivers epinephrine after a bee sting.
Over the course of the summer, the Werner laboratory continued work on non-antibodybased treatment for venomous snake bites, expanding on the research of a former S3
scholar, Lauren Miling, (Werner, R.M.; Miling, L.M. et al.,2020) who found that the
bacteriological production of a soluble opossum SVMPI protein was enhanced through
the use of a protein fusion with maltose binding protein (MBP). This fusion protein
included a protease site recognized by Factor Xa. The attempts to cleave the fusion
protein with Factor Xa and isolate the purified SVMPI were unsuccessful because of
non-specific protein cleavage. We used tobacco etch virus (TEV) protease in place of
Factor Xa in an attempt to limit non-specific protein cleavage since TEV is a more
specific protease. This project focused on the production of eight plasmid expression
vectors and the optimization of the enzymatic cleavage reaction between a model fusion
protein, MBP-NusG, and TEV protease. The eight plasmid expression vectors were
produced through Gibson Assembly. These vectors contained 6-histidine tags and
maltose binding proteins (MBP), the coding sequence for either DM43 (a SVMPI
inhibitor) or DM64 (aPLA2 inhibitor), and a Tobacco etch virus (TEV) cleavage site.

Methods and Materials
Reagents and Materials

6
LB media, tryptone, yeast extract, agar, agarose, ethidium bromide, sodium chloride,
calcium chloride, sodium phosphate, Tris-HCl, Tris base, ampicillin, kanamycin, EDTA
(ethylenediamine tetraacetic acid), ethanol, methanol, DMSO (dimethylsulfoxide), DTT
(dithiothreitol), and IPTG (Isopropyl β-D-1-thiogalactopyranoside) were obtained from
Sigma (St. Louis, MO). The pMAL-c6t plasmid, NEBuilder HiFi DNA assembly 2X
master mix, Q5 Hot Start High-Fidelity 2X Master Mix, OneTaq 2X Master Mix with
standard buffer, NEB 5-α competent E. coli (High Efficiency), NEBExpress competent E.
coli (High Efficiency), Monarch Plasmid Miniprep Kit, Monarch DNA Gel Extraction Kit,
CutSmart buffer 10X, restriction enzymes (XmnI, DpnI, BamHI-HF, NcoI-HF, XbaI),
Purple 6X-load dye, and 1KB Molecular Weight DNA ladder were obtained from New
England Biolabs (NEB) (Ipswich, MA). Wizard Plasmid Miniprep Kit was obtained from
Promega (Madison, WI). BL21(DE3) competent E. coli cells were obtained from
EMDMillipore (Burlington, MA). HiPur Ni-NTA Resin and HALT protease inhibitor were
obtained from ThermoFisher Scientific (Waltham, MA). All disposable plasticware and
both clear and black 96-well microplates were from VWR International (Radnor,
PA). Mini-PROTEAN Tetra vertical electrophoresis cell, 4–20% Mini-PROTEAN TGX
SDS-PAGE pre-cast protein gels, microcentrifuge tube roller, 10X Tris-Glycine SDSPAGE buffer, 2X Laemmli sample buffer, protein assay dye concentrate (Bradford
reagent), and Precision Plus Protein Kaleidoscope pre-stained protein molecular weight
standard were from Bio-Rad (Hercules, CA). 2-aminobenzoyl-Ala-Gly-Leu-Ala-4nitrobenzylamide (Abz-NGLA-Nbz) was obtained from Peptides International (Louisville,
KY). Freeze-dried Crotalus atrox (C. atrox) venom was obtained from the National
Natural Toxins Research Center at Texas A&M Kingsville. Synthetic desalted PCR
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primers (all primer sequences listed in the supplemental section) were obtained from
Integrated DNA Technologies (Skokie, IL). A synthetic DNA encoding for the oprin
DM43-like gene-product derived from a D. virginiana cDNA sequence (GenBank
Accession number AY131001.1) inserted into the pUC19 vector was obtained from
GeneScript Corporation (Piscataway, NJ). This pUC19-oprin construct contained
HindIII restriction sites immediately upstream and downstream of the oprin coding
sequence (876 bp) as well as an inserted TGA stop codon at the 3’-end of the sequence
(see supplemental information for complete pUC19-oprin DM43-like vector sequence).
General Methods
PCR was performed using specific primers (found in table on pages 52-53) and an
Applied Biosystems Veriti thermocycler Model 9902 (ThermoFisher Scientific Waltham,
MA), DNA visualization was performed using 1.0% agarose gels stained with EtBr and
DNA concentration was measured with a microvolume UV spectrophotometer, namely
the NanoDrop2000 (ThermoFisher Scientific Waltham, MA). LB/Amp and LB/Kan liquid
media and plates had final ampicillin and kanamycin concentrations of 100 mg/L and 30
mg/L, respectively. Proteins were concentrated using Amicon Ultra (10K MWCO)
centrifugal concentrators. Protein concentrations were measured using either the BioRad Bradford (Bradford, 1976) protein assay (Hercules, CA) or proteins were diluted in
8M guanidine hydrochloride followed by micro-cuvette UV-vis measurements using an
Agilent Cary 60 UV-Vis spectrophotometer and calculated extinction coefficients
(ExPASy ProtParam tool).(Gasteiger et al.,2005) Protein electrophoresis was performed
with either a Bio-Rad (Hercules, CA) Mini-Protean 3 Cell or a Mini Trans-Blot
Electrophoretic Transfer Cell. SDS-PAGE gels were stained with Coomassie blue
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stain. Micro-plate assays (for protein concentration and kinetic fluorescent assays)
were performed using a BioTek Synergy H1 Hybrid Reader (Winooski,
VT). Centrifugation was accomplished using either a fixed angle VWR BenchMate
micro-centrifuge, an Eppendorf 5417C microcentrifuge, a ThermoScientific Sorvall Lynx
400 fixed angle centrifuge, or a ThermoScientific Sorvall Legend X1 swinging bucket
centrifuge. Sanger di-deoxy sequencing was performed at either Univeristy of Michigan
Sequencing Core (Ann Arbor, MI) or Macrogen (Rockville, MD). IC50 values were
calculated using GraphPad Prism version 8.4.2 for Windows, GraphPad Software (San
Diego, CA)
Gibson Assembly of TEV Constructs
(Assembly 1) Gibson Assembly of pMAL-c6t-TEV-DM43 expression vector
Linearization of the pMAL-c6t vector (New England Biolabs) was accomplished using
Q5 Hot Start High-Fidelity Polymerase 2X master mix with primers C and D (primer
sequences provided in supplemental). The 25 μL PCR reaction contained: 12.5 μL of
Q5 2X master mix, 1.25 μL of 10 μM primer C, 1.25 μL of 10 μM primer D, 1 μL of
pMAL-c6t template DNA (~1 pg), and 9 μL ultrapure H2O. PCR thermocycler reaction
conditions for the construction of the pMAL-c6t assembly fragment were: Stage 1: 60
sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 65 oC, 4.0 min 72 oC (35 cycles); Stage 3:
10.0 min 72 oC; Stage 4: 4 oC.
To introduce overlapping pMAL-c6t regions on both ends of the oprin(DM43) coding
sequence, the appropriate region of the synthetic pUC19-oprin(DM43) plasmid
(Genescript) was amplified using Q5 Hot Start High-Fidelity Polymerase 2X master mix
and primers E and F. The 25 μL PCR reaction contained: 12.5 μL of Q5 2X master mix,
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1.25 μL of 10 μM primer E, 1.25 μL of 10 μM primer F, 1 μL (~2 pg) of synthetic pUC19oprin(DM43) template DNA, and 9 μL ultrapure H 2O. PCR thermocycler reaction
conditions for the construction of the oprin assembly fragment were: Stage 1: 60 sec 98
oC;

Stage 2: 30 sec 98 oC, 30 sec 65 oC, 30 sec 72 oC (35 cycles); Stage 3: 10 min 72

oC;

Stage 4: 4 oC. Assembly fragment lengths were verified by 1% agarose gel (stained

with EtBr) (see supplemental), bands were excised, DNA was isolated using a Monarch
DNA Gel Extraction Kit, and DNA concentration was determined using a micro-volume
spectrophotometer.

Lane
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1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
PCR reaction
Prior to Gibson Assembly, linearized pMAL-c6t was treated with DpnI for 30 min at 37
oC

in a reaction containing 8 μL (134 ng) of linearized pMAL-c6t, 1 μL of 10X CutSmart

buffer, and 1 μL (20 units) of DpnI, followed by 20 min heat inactivation at 80
o

C. Gibson Assembly conditions were as follows: 0.06 pmol of the pMAL-c6t linearized

fragment (vector) and 0.12 pmol of the oprin(DM43) assembly fragment (insert) (~1:2
vector/insert ratio) were combined in a 20 μL assembly reaction with 10 μL of NEBuilder
HiFi DNA 2X assembly master mix and held at 50 oC for 30 min. NEB 5-α competent E.
coli cells (NEB) were then transformed with 2 μL of this assembly reaction following the
manufacturer’s 42 oC heat-shock protocol, incubated in SOC media at 37 oC for 60 min,
and 100 μL was then spread on LB/Amp agar plates, and incubated at 37 oC overnight.
Colony PCR of Gibson Assembly transformation colonies
Six colonies from Assembly 1 were randomly screened by colony PCR in separate 25
μL reactions using OneTaq Quick-Load 2X Master Mix with standard buffer and DM43
specific primers A and B (876 BP amplicon). PCR reactions contained: 12.5 μL
OneTaq, 1.25 μL of 10 μM primer A, 1.25 μL of 10 μM of primer B, and 10 μL ultrapure
H2O, and individual colonies were picked with a sterile micro-pipette tip as the DNA
source (note: these same tips were used to inoculate separate 10 mL LB/Amp cultures
grown overnight at 37 oC with shaking at 250 rpm. PCR thermocycler conditions for
colony PCR were: Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 56 oC, 60 sec 68
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oC

(35 cycles); Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were

visualized by 1.0% agarose gel (stained with EtBr) (see supplemental). (Note: a
negative control reaction with no DNA and a negative primer control with only one
primer were also run – Lanes 7 and 8 respectively)

Lane
1. 1KB DNA ladder
2. Blank
3. Colony 1A
4. Colony 1B
5. Colony 1C
6. Colony 1D
7. Colony 1E
8. Colony 1F
9. Negative control
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10. Primer negative control
DNA isolation and sequencing
Plasmid DNA from the three Assembly 1 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from
colony PCR as visualized by 1.0% agarose gel (stained with EtBr) using a Miniprep Kit
(NEB or Promega), eluted with 20 μL of elution buffer to give final plasmid DNA
concentrations between 20-120 ng/ μL as measured using a micro-volume
spectrophotometer. Three of these purified plasmids were submitted for Sanger
dideoxy-sequencing (MCLAB, South San Francisco, CA) using primers AA and
BB. Reads were trimmed and aligned (data not shown) using freeware FinchTV and
UniProUGENE software (see supplemental for plasmid map and complete DNA and
putative protein sequences).(FinchTV; Okonechnikov et al., 2012)
Transformation of Assembly 1
The pMAL-c6t-oprin construct from Assembly 1 was transformed into NEBExpress E.
coli cells (NEB) following the manufacture’s protocol. This strain is recommended for
the expression of MPB-fusion proteins because it is ideal for Ptac expression vectors
such as pMAL-c6t and is deficient in proteases Lon and OmpT. The transformed cells
(100 μL) were then spread onto LB/Amp plates and grown overnight at 37 oC.
Expression and purification of Assembly 1 (6-His-MBP-TEV-DM43 fusion protein)
Four transformed colonies of NEBExpress E. coli containing the 6-His-MBP-TEV-DM43
constructs from Assembly 1 were screened for IPTG-induced protein production by
inoculating four separate 10 mL liquid LB/Amp media tubes containing 1 mM IPTG,
incubated at 37 oC with overnight shaking at 250 rpm, and protein production was
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assessed via SDS-PAGE inspection. Once screened, the transformation colony
showing the most IPTG-induced protein production was subjected to large-scale
expression of the N-terminal MBP-oprin protein. This was accomplished by inoculating
1 L of liquid LB/Amp/Glu (containing 1mM glucose) media with a 10 mL starter culture of
NEBExpress E. coli cells containing the previously screened Assembly 2 transformed
colony. (Note: The addition of glucose is recommended as it inhibits the production of
amylase, an enzyme that can degrade the amylose resin used in subsequent
purification steps). Cells were initially incubated at 37 oC with shaking at 250 rpm until
the cultures reached 0.4 OD600, the temperature was then decreased to 30 oC, IPTG
(final concentration of 1 mM) was added and the cells were incubated at 30 oC for an
additional six hours. (Note: we found that if cultures were grown at 37 oC or for
extended time periods, significant inclusion body formation was observed, data not
shown). The cells were then harvested at 4,000 G at 4 oC, the supernatant was
decanted, and the cell pellets were frozen at -20 oC overnight. The cell pellets were resuspended in a total of 60 mL of column buffer (20 mM Tris-HCl pH 7.4, 200 mM NaCl,
1 mM EDTA, and 0.5 mM DTT) containing 10 mg lysozyme and 100 μL HALT protease
inhibitor (Sigma). (Note: The addition of lysozyme and the protease inhibitor cocktail
increased recovery of soluble MBP-oprin fusion protein significantly, data not
shown). The sample was incubated on ice for 10 minutes to induce cell lysis, sonicated
with ten 30 sec bursts at 25 Hz on ice, and centrifuged at 15,000 x G for 20 min at 4
oC.

Affinity Purification with Ni-column
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The combined supernatants were decanted and purified at 25 oC using 5 cm3 of HisPur
Ni-NTA resin (ThermoScientific) according to the manufacture’s protocol. The resin was
equilibrated with 30 mL lysis buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 10 mM
imidazole), the entire cell free lysate supernatant added to the resin and gently shaken
at 4 oC for 1 hr. This mixture was poured into a glass column and washed using 100 mL
of wash buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 25 mM imidazole) with a flow rate
of 4.0 mL/min. The target protein was eluted in 2.0 mL fractions using elution buffer (25
mM Tris-HCl pH 8, 400 mM NaCl, 0.5 M imidazole) with a flow rate of 4.0
mL/min. Eluted fractions were examined for quantity and purity using the Bradford
protein assay and SDS-PAGE, the fractions containing purified MBP-TEV-DM43
pooled.
Affinity Purification with Amylose-column
The pooled Ni-purified fractions were applied to 40 cm3 of amylose resin (NEB)
equilibrated in column buffer with 1M NaCl added (Note: the addition of NaCl to the
column buffer for equilibration and rinsing of the amylose column significantly reduced
non-specific binding, see supplemental). A flow rate of 4.0 mL/min was used to rinse
the column with 100 mL of column buffer with 1M NaCl added, and the MBP-TEV-DM43
fusion protein was eluted into 3 mL fractions with column buffer containing 10 mM
maltose but lacking the added 1M NaCl. Eluted fractions were examined for quantity
and purity using the Bradford protein assay and SDS-PAGE, the fractions containing the
purified MBP-TEV-DM43 fusion protein were pooled and concentrated to a final
concentration of 5.0 mg/ml (~67 nM, based on a calculated molecular weight of 75,001
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g/mol and a calculated extinction coefficient of 122,245 M-1cm-1) (values obtained from
the ExPASy ProtParam tool).(Gasteiger et al., 2005)
(Assembly 2) Gibson Assembly of pMAL-c6t-TEV-DM43 (Ala) expression vector
Linearization of the pMAL-c6t vector (New England Biolabs) was accomplished using
Q5 Hot Start High-Fidelity Polymerase 2X master mix with primers C and D (primer
sequences provided in supplemental). The 25 μL PCR reaction contained: 12.5 μL of
Q5 2X master mix, 1.25 μL of 10 μM primer C, 1.25 μL of 10 μM primer D, 1 μL of
pMAL-c6t template DNA (~1 pg), and 9 μL ultrapure H2O. PCR thermocycler reaction
conditions for the construction of the pMAL-c6t assembly fragment were: Stage 1: 60
sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 65 oC, 4.0 min 72 oC (35 cycles); Stage 3:
10.0 min 72 oC; Stage 4: 4 oC.
To introduce overlapping pMAL-c6t regions on both ends of the oprin(DM43) (L1A
mutant) coding sequence, the appropriate region of the synthetic pUC19-oprin(DM43)
plasmid (Genescript) was amplified using Q5 Hot Start High-Fidelity Polymerase 2X
master mix and primers G and H. The 25 μL PCR reaction contained: 12.5 μL of Q5 2X
master mix, 1.25 μL of 10 μM primer G, 1.25 μL of 10 μM primer H, 1 μL (~2 pg) of
synthetic pUC19-oprin(DM43) template DNA, and 9 μL ultrapure H 2O. PCR
thermocycler reaction conditions for the construction of the oprin assembly fragment
were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 65 oC, 30 sec 72 oC (35
cycles); Stage 3: 10 min 72 oC; Stage 4: 4 oC. Assembly fragment lengths were verified
by 1.0% agarose gel (stained with EtBr) (see supplemental), bands were excised, DNA
was isolated using a Monarch DNA Gel Extraction Kit, and DNA concentration was
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determined using a micro-volume spectrophotometer.

Lane
1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
4 oprin insert (876 BP) – previously synthesized
5 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of PCR reaction
6 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of
Prior to Gibson Assembly, linearized pMAL-c6t was treated with DpnI for 30 min at 37
o

C in a reaction containing 8 μL (134 ng) of linearized pMAL-c6t, 1 μL of 10X CutSmart

buffer, and 1 μL (20 units) of DpnI, followed by 20 min heat inactivation at 80
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oC.

Gibson Assembly conditions were as follows: 0.06 pmol of the pMAL-c6t linearized

fragment (vector) and 0.12 pmol of the oprin(DM43) (L1A mutant) assembly fragment
(insert) (~1:2 vector/insert ratio) were combined in a 20 μL assembly reaction with 10 μL
of NEBuilder HiFi DNA 2X assembly master mix and held at 50 oC for 30 min. NEB 5-α
competent E. coli cells (NEB) were then transformed with 2 μL of this assembly reaction
following the manufacturer’s 42 oC heat-shock protocol, incubated in SOC media at 37
oC
o

for 60 min, and 100 μL was then spread on LB/Amp agar plates, and incubated at 37

C overnight.

Colony PCR of Gibson Assembly transformation colonies
Colonies from Assembly 2 were screened by colony PCR in separate reactions using
OneTaq Quick-Load 2X Master Mix with standard buffer and DM43 specific primers A
and B (876 BP amplicon). Six colonies from the Gibson Assembly were randomly
screened in separate 25 μL PCR reactions containing: 12.5 μL OneTaq, 1.25 μL of 10
μM primer A, 1.25 μL of 10 μM of primer B, and 10 μL ultrapure H2O, and individual
colonies were picked with a sterile micro-pipette tip as the DNA source (note: these
same tips were used to inoculate separate 10 mL LB/Amp cultures grown overnight at
37 oC with shaking at 250 rpm. PCR thermocycler conditions for colony PCR were:
Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 56 oC, 60 sec 68 oC (35 cycles);
Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were visualized by 1.0%
agarose gel (stained with EtBr) (see supplemental). (Note: a negative control reaction
with no DNA and a negative primer control with only one primer were also run – Lanes 7
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and 8 respectively

Lane
1. 1KB DNA ladder
2. Blank
3. Colony 2A
4. Colony 2B
5. Colony 2C
6. Colony 2D
7. Colony 2E
8. Colony 2F
9. Negative control
10. Primer negative control
DNA isolation and sequencing
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Plasmid DNA from the three Assembly 2 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from
colony PCR as visualized by 1.0% agarose gel (stained with EtBr) using a Miniprep Kit
(NEB or Promega), eluted with 20 μL of elution buffer to give final plasmid DNA
concentrations between 20-120 ng/ μL as measured using a micro-volume
spectrophotometer. Three of these purified plasmids were submitted for Sanger
dideoxy-sequencing (MCLAB, South San Francisco, CA) using primers AA and
BB. Reads were trimmed and aligned (data not shown) using freeware FinchTV and
UniProUGENE software (see supplemental for plasmid map and complete DNA and
putative protein sequences).(FinchTV; Okonechnikov et al., 2012)
Transformation of Assembly 2
The pMAL-c6t-oprin construct from Assembly 2 was transformed into NEBExpress E.
coli cells (NEB) following the manufacture’s protocol. This strain is recommended for
the expression of MPB-fusion proteins because it is ideal for Ptac expression vectors
such as pMAL-c6t and is deficient in proteases Lon and OmpT. The transformed cells
(100 μL) were then spread onto LB/Amp plates and grown overnight at 37 oC.
Expression and purification of Assembly (6-His-MBP-TEV-DM43 (L1A) fusion protein)
Four transformed colonies of NEBExpress E. coli containing the 6-His-MBP-TEV-DM43
(L1A) constructs from Assembly 1 were screened for IPTG-induced protein production
by inoculating four separate 10 mL liquid LB/Amp media tubes containing 1 mM IPTG,
incubated at 37 oC with overnight shaking at 250 rpm, and protein production was
assessed via SDS-PAGE inspection. Once screened, the transformation colony
showing the most IPTG-induced protein production was subjected to large-scale
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expression of the N-terminal MBP-oprin protein. This was accomplished by inoculating
1 L of liquid LB/Amp/Glu (containing 1mM glucose) media with a 10 mL starter culture of
NEBExpress E. coli cells containing the previously screened Assembly 2 transformed
colony. (Note: The addition of glucose is recommended as it inhibits the production of
amylase, an enzyme that can degrade the amylose resin used in subsequent
purification steps). Cells were initially incubated at 37 oC with shaking at 250 rpm until
the cultures reached 0.4 OD600, the temperature was then decreased to 30 oC, IPTG
(final concentration of 1 mM) was added and the cells were incubated at 30 oC for an
additional six hours. (Note: we found that if cultures were grown at 37 oC or for
extended time periods, significant inclusion body formation was observed, data not
shown). The cells were then harvested at 4,000 G at 4 oC, the supernatant was
decanted, and the cell pellets were frozen at -20 oC overnight. The cell pellets were resuspended in a total of 60 mL of column buffer (20 mM Tris-HCl pH 7.4, 200 mM NaCl,
1 mM EDTA, and 0.5 mM DTT) containing 10 mg lysozyme and 100 μL HALT protease
inhibitor (Sigma). (Note: The addition of lysozyme and the protease inhibitor cocktail
increased recovery of soluble MBP-oprin fusion protein significantly, data not
shown). The sample was incubated on ice for 10 minutes to induce cell lysis, sonicated
with ten 30 sec bursts at 25 Hz on ice, and centrifuged at 15,000 x G for 20 min at 4
oC.

Affinity Purification with Ni-column
The combined supernatants were decanted and purified at 25 oC using 5 cm3 of HisPur
Ni-NTA resin (ThermoScientific) according to the manufacture’s protocol. The resin was
equilibrated with 30 mL lysis buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 10 mM
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imidazole), the entire cell free lysate supernatant added to the resin and gently shaken
at 4 oC for 1 hr. This mixture was poured into a glass column and washed using 100 mL
of wash buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 25 mM imidazole) with a flow rate
of 4.0 mL/min. The target protein was eluted in 2.0 mL fractions using elution buffer (25
mM Tris-HCl pH 8, 400 mM NaCl, 0.5 M imidazole) with a flow rate of 4.0
mL/min. Eluted fractions were examined for quantity and purity using the Bradford
protein assay and SDS-PAGE, the fractions containing purified MBP-TEV-DM43 (L1A)
pooled.
Affinity Purification with Amylose-column
The pooled Ni-purified fractions were applied to 40 cm3 of amylose resin (NEB)
equilibrated in column buffer with 1M NaCl added (Note: the addition of NaCl to the
column buffer for equilibration and rinsing of the amylose column significantly reduced
non-specific binding, see supplemental). A flow rate of 4.0 mL/min was used to rinse
the column with 100 mL of column buffer with 1M NaCl added, and the MBP-TEV-DM43
(L1A) fusion protein was eluted into 3 mL fractions with column buffer containing 10
mM maltose but lacking the added 1M NaCl. Eluted fractions were examined for
quantity and purity using the Bradford protein assay and SDS-PAGE, the fractions
containing the purified MBP-TEV-DM43 (L1A) fusion protein were pooled and
concentrated to a final concentration of 5.0 mg/ml (~67 nM, based on a calculated
molecular weight of 75,001 g/mol and a calculated extinction coefficient of 122,245 M 1cm-1)

(values obtained from the ExPASy ProtParam tool).(Gasteiger et al., 2005)

(Assembly 3) Gibson Assembly of pMAL-c6t-TEV-DM64 expression vector
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Linearization of the pMAL-c6t vector (New England Biolabs) was accomplished using
Q5 Hot Start High-Fidelity Polymerase 2X master mix with primers C and D (primer
sequences provided in supplemental). The 25 μL PCR reaction contained: 12.5 μL of
Q5 2X master mix, 1.25 μL of 10 μM primer C, 1.25 μL of 10 μM primer D, 1 μL of
pMAL-c6t template DNA (~1 pg), and 9 μL ultrapure H2O. PCR thermocycler reaction
conditions for the construction of the pMAL-c6t assembly fragment were: Stage 1: 60
sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 65 oC, 4.0 min 72 oC (35 cycles); Stage 3:
10.0 min 72 oC; Stage 4: 4 oC.
To introduce overlapping pMAL-c6t regions on both ends of the DM64 coding
sequence, the appropriate region of the synthetic pUC19-DM64 plasmid (BioTwist) was
amplified using Q5 Hot Start High-Fidelity Polymerase 2X master mix and primers I and
J. The 25 μL PCR reaction contained: 12.5 μL of Q5 2X master mix, 1.25 μL of 10 μM
primer I, 1.25 μL of 10 μM primer J, 1 μL (~2 pg) of synthetic pUC19-DM64 template
DNA, and 9 μL ultrapure H2O. PCR thermocycler reaction conditions for the
construction of the DM64 assembly fragment were: Stage 1: 60 sec 98 oC; Stage 2: 30
sec 98 oC, 30 sec 66 oC, 60 sec 72 oC (35 cycles); Stage 3: 10 min 72 oC; Stage 4: 4
oC.

Assembly fragment lengths were verified by 1.0% agarose gel (stained with EtBr)

(see supplemental), bands were excised, DNA was isolated using a Monarch DNA Gel
Extraction Kit, and DNA concentration was determined using a micro-volume
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spectrophotometer.

Lane
1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
4 oprin insert (876 BP) – previously synthesized
5 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of PCR reaction
6 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of
Prior to Gibson Assembly, linearized pMAL-c6t was treated with DpnI for 30 min at 37
oC

in a reaction containing 8 μL (134 ng) of linearized pMAL-c6t, 1 μL of 10X CutSmart

buffer, and 1 μL (20 units) of DpnI, followed by 20 min heat inactivation at 80
oC.

Gibson Assembly conditions were as follows: 0.06 pmol of the pMAL-c6t linearized
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fragment (vector) and 0.12 pmol of the DM64 assembly fragment (insert) (~1:2
vector/insert ratio) were combined in a 20 μL assembly reaction with 10 μL of NEBuilder
HiFi DNA 2X assembly master mix and held at 50 oC for 30 min. NEB 5-α competent E.
coli cells (NEB) were then transformed with 2 μL of this assembly reaction following the
manufacturer’s 42 oC heat-shock protocol, incubated in SOC media at 37 oC for 60 min,
and 100 μL was then spread on LB/Amp agar plates, and incubated at 37 oC overnight.
Colony PCR of Gibson Assembly transformation colonies
Colonies from Assembly 3 were screened by colony PCR in separate reactions using
OneTaq Quick-Load 2X Master Mix with standard buffer and DM64 specific primers W
and X (1440 BP amplicon). Six colonies from the Gibson Assembly were randomly
screened in separate 25 μL PCR reactions containing: 12.5 μL OneTaq, 1.25 μL of 10
μM primer W, 1.25 μL of 10 μM of primer X, and 10 μL ultrapure H 2O, and individual
colonies were picked with a sterile micro-pipette tip as the DNA source (note: these
same tips were used to inoculate separate 10 mL LB/Amp cultures grown overnight at
37 oC with shaking at 250 rpm. PCR thermocycler conditions for colony PCR were:
Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 60 oC, 60 sec 68 oC (35 cycles);
Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were visualized by 1.0%
agarose gel (stained with EtBr) (see supplemental). (Note: a negative control reaction
with no DNA and a negative primer control with only one primer were also run – Lanes 7
and 8 respectively)
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Lane
1. 1KB DNA ladder
2. Colony 3A
3. Colony 3B
4. Colony 3C
5. Colony 3D
6. Colony 3E
7. Colony 3F
8. Negative control
9. Primer negative control
DNA isolation and sequencing
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Plasmid DNA from the three Assembly 3 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from
colony PCR as visualized by 1.0% agarose gel (stained with EtBr) using a Miniprep Kit
(NEB or Promega), eluted with 20 μL of elution buffer to give final plasmid DNA
concentrations between 20-120 ng/ μL as measured using a micro-volume
spectrophotometer. Three of these purified plasmids were submitted for Sanger
dideoxy-sequencing (MCLAB, South San Francisco, CA) using primers AA and
BB. Reads were trimmed and aligned (data not shown) using freeware FinchTV and
UniProUGENE software (see supplemental for plasmid map and complete DNA and
putative protein sequences).(FinchTV; Okonechnikov et al., 2012)
Transformation of Assembly 3
The pMAL-c6t-oprin construct from Assembly 3 was transformed into NEBExpress E.
coli cells (NEB) following the manufacture’s protocol. This strain is recommended for
the expression of MPB-fusion proteins because it is ideal for Ptac expression vectors
such as pMAL-c6t and is deficient in proteases Lon and OmpT. The transformed cells
(100 μL) were then spread onto LB/Amp plates and grown overnight at 37 oC.
Expression and purification of Assembly 3 (6-His-MBP-TEV-DM64 fusion protein)
Four transformed colonies of NEBExpress E. coli containing the 6-His-MBP-TEV-DM64
constructs from Assembly 3 were screened for IPTG-induced protein production by
inoculating four separate 10 mL liquid LB/Amp media tubes containing 1 mM IPTG,
incubated at 37 oC with overnight shaking at 250 rpm, and protein production was
assessed via SDS-PAGE inspection. Once screened, the transformation colony
showing the most IPTG-induced protein production was subjected to large-scale
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expression of the N-terminal MBP-oprin protein. This was accomplished by inoculating
1 L of liquid LB/Amp/Glu (containing 1mM glucose) media with a 10 mL starter culture of
NEBExpress E. coli cells containing the previously screened Assembly 2 transformed
colony. (Note: The addition of glucose is recommended as it inhibits the production of
amylase, an enzyme that can degrade the amylose resin used in subsequent
purification steps). Cells were initially incubated at 37 oC with shaking at 250 rpm until
the cultures reached 0.4 OD600, the temperature was then decreased to 30 oC, IPTG
(final concentration of 1 mM) was added and the cells were incubated at 30 oC for an
additional six hours. (Note: we found that if cultures were grown at 37 oC or for
extended time periods, significant inclusion body formation was observed, data not
shown). The cells were then harvested at 4,000 G at 4 oC, the supernatant was
decanted, and the cell pellets were frozen at -20 oC overnight. The cell pellets were resuspended in a total of 60 mL of column buffer (20 mM Tris-HCl pH 7.4, 200 mM NaCl,
1 mM EDTA, and 0.5 mM DTT) containing 10 mg lysozyme and 100 μL HALT protease
inhibitor (Sigma). (Note: The addition of lysozyme and the protease inhibitor cocktail
increased recovery of soluble MBP-oprin fusion protein significantly, data not
shown). The sample was incubated on ice for 10 minutes to induce cell lysis, sonicated
with ten 30 sec bursts at 25 Hz on ice, and centrifuged at 15,000 x G for 20 min at 4
oC.

Affinity Purification with Ni-column
The combined supernatants were decanted and purified at 25 oC using 5 cm3 of HisPur
Ni-NTA resin (ThermoScientific) according to the manufacture’s protocol. The resin was
equilibrated with 30 mL lysis buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 10 mM
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imidazole), the entire cell free lysate supernatant added to the resin and gently shaken
at 4 oC for 1 hr. This mixture was poured into a glass column and washed using 100 mL
of wash buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 25 mM imidazole) with a flow rate
of 4.0 mL/min. The target protein was eluted in 2.0 mL fractions using elution buffer (25
mM Tris-HCl pH 8, 400 mM NaCl, 0.5 M imidazole) with a flow rate of 4.0
mL/min. Eluted fractions were examined for quantity and purity using the Bradford
protein assay and SDS-PAGE, the fractions containing purified MBP-TEV-DM64
pooled.
Affinity Purification with Amylose-column
The pooled Ni-purified fractions were applied to 40 cm3 of amylose resin (NEB)
equilibrated in column buffer with 1M NaCl added (Note: the addition of NaCl to the
column buffer for equilibration and rinsing of the amylose column significantly reduced
non-specific binding, see supplemental). A flow rate of 4.0 mL/min was used to rinse
the column with 100 mL of column buffer with 1M NaCl added, and the MBP-TEV-DM64
fusion protein was eluted into 3 mL fractions with column buffer containing 10 mM
maltose but lacking the added 1M NaCl. Eluted fractions were examined for quantity
and purity using the Bradford protein assay and SDS-PAGE, the fractions containing the
purified MBP-TEV-DM64 fusion protein were pooled and concentrated to a final
concentration of 5.0 mg/ml (~67 nM, based on a calculated molecular weight of 75,001
g/mol and a calculated extinction coefficient of 122,245 M-1cm-1) (values obtained from
the ExPASy ProtParam tool).(Gasteiger et al., 2005)
(Assembly 4) Gibson Assembly of pMAL-c6t-TEV-DM64 (Ala) expression vector
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Linearization of the pMAL-c6t vector (New England Biolabs) was accomplished using
Q5 Hot Start High-Fidelity Polymerase 2X master mix with primers C and D (primer
sequences provided in supplemental). The 25 μL PCR reaction contained: 12.5 μL of
Q5 2X master mix, 1.25 μL of 10 μM primer C, 1.25 μL of 10 μM primer D, 1 μL of
pMAL-c6t template DNA (~1 pg), and 9 μL ultrapure H2O. PCR thermocycler reaction
conditions for the construction of the pMAL-c6t assembly fragment were: Stage 1: 60
sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 65 oC, 4.0 min 72 oC (35 cycles); Stage 3:
10.0 min 72 oC; Stage 4: 4 oC.
To introduce overlapping pMAL-c6t regions on both ends of the DM64 (L1A mutant)
coding sequence, the appropriate region of the synthetic pUC19-DM64 plasmid
(BioTwist) was amplified using Q5 Hot Start High-Fidelity Polymerase 2X master mix
and primers K and L. The 25 μL PCR reaction contained: 12.5 μL of Q5 2X master
mix, 1.25 μL of 10 μM primer K, 1.25 μL of 10 μM primer L, 1 μL (~2 pg) of synthetic
pUC19-DM64 template DNA, and 9 μL ultrapure H2O. PCR thermocycler reaction
conditions for the construction of the DM64 assembly fragment were: Stage 1: 60 sec
98 oC; Stage 2: 30 sec 98 oC, 30 sec 67 oC, 60 sec 72 oC (35 cycles); Stage 3: 10 min
72 oC; Stage 4: 4 oC. Assembly fragment lengths were verified by 1.0% agarose gel
(stained with EtBr) (see supplemental), bands were excised, DNA was isolated using a
Monarch DNA Gel Extraction Kit, and DNA concentration was determined using a
micro-volume spectrophotometer.
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Lane
1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
4 oprin insert (876 BP) – previously synthesized
5 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of PCR reaction
6 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of
Prior to Gibson Assembly, linearized pMAL-c6t was treated with DpnI for 30 min at 37
oC

in a reaction containing 8 μL (134 ng) of linearized pMAL-c6t, 1 μL of 10X CutSmart

buffer, and 1 μL (20 units) of DpnI, followed by 20 min heat inactivation at 80
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oC.

Gibson Assembly conditions were as follows: 0.06 pmol of the pMAL-c6t linearized

fragment (vector) and 0.12 pmol of the DM64 assembly fragment (insert) (~1:2
vector/insert ratio) were combined in a 20 μL assembly reaction with 10 μL of NEBuilder
HiFi DNA 2X assembly master mix and held at 50 oC for 30 min. NEB 5-α competent E.
coli cells (NEB) were then transformed with 2 μL of this assembly reaction following the
manufacturer’s 42 oC heat-shock protocol, incubated in SOC media at 37 oC for 60 min,
and 100 μL was then spread on LB/Amp agar plates, and incubated at 37 oC overnight.
Colony PCR of Gibson Assembly transformation colonies
Colonies from Assembly 4 were screened by colony PCR in separate reactions using
OneTaq Quick-Load 2X Master Mix with standard buffer and DM64 specific primers W
and X (1440 BP amplicon). Six colonies from the Gibson Assembly were randomly
screened in separate 25 μL PCR reactions containing: 12.5 μL OneTaq, 1.25 μL of 10
μM primer W, 1.25 μL of 10 μM of primer X, and 10 μL ultrapure H 2O, and individual
colonies were picked with a sterile micro-pipette tip as the DNA source (note: these
same tips were used to inoculate separate 10 mL LB/Amp cultures grown overnight at
37 oC with shaking at 250 rpm. PCR thermocycler conditions for colony PCR were:
Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 60 oC, 60 sec 68 oC (35 cycles);
Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were visualized by 1.0%
agarose gel (stained with EtBr) (see supplemental). (Note: a negative control reaction
with no DNA and a negative primer control with only one primer were also run – Lanes 7
and 8 respectively)
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Lane
1. 1KB DNA ladder
2. Colony 4A
3. Colony 4B
4. Colony 4C
5. Colony 4D
6. Colony 4E
7. Colony 4F
8. Negative control
DNA isolation and sequencing
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Plasmid DNA from the three Assembly 4 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from
colony PCR as visualized by 1.0% agarose gel (stained with EtBr) using a Miniprep Kit
(NEB or Promega), eluted with 20 μL of elution buffer to give final plasmid DNA
concentrations between 20-120 ng/ μL as measured using a micro-volume
spectrophotometer. Three of these purified plasmids were submitted for Sanger
dideoxy-sequencing (MCLAB, South San Francisco, CA) using primers AA and
BB. Reads were trimmed and aligned (data not shown) using freeware FinchTV and
UniProUGENE software (see supplemental for plasmid map and complete DNA and
putative protein sequences).(FinchTV; Okonechnikov et al., 2012)
Transformation of Assembly 4
The pMAL-c6t-oprin construct from Assembly 4 was transformed into NEBExpress E.
coli cells (NEB) following the manufacture’s protocol. This strain is recommended for
the expression of MPB-fusion proteins because it is ideal for Ptac expression vectors
such as pMAL-c6t and is deficient in proteases Lon and OmpT. The transformed cells
(100 μL) were then spread onto LB/Amp plates and grown overnight at 37 oC.
Expression and purification of Assembly 4 (6-His-MBP-TEV-DM64 (L1A) fusion protein)
Four transformed colonies of NEBExpress E. coli containing the 6-His-MBP-TEV-DM64
(L1A) constructs from Assembly 4 were screened for IPTG-induced protein production
by inoculating four separate 10 mL liquid LB/Amp media tubes containing 1 mM IPTG,
incubated at 37 oC with overnight shaking at 250 rpm, and protein production was
assessed via SDS-PAGE inspection. Once screened, the transformation colony
showing the most IPTG-induced protein production was subjected to large-scale
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expression of the N-terminal MBP-oprin protein. This was accomplished by inoculating
1 L of liquid LB/Amp/Glu (containing 1mM glucose) media with a 10 mL starter culture of
NEBExpress E. coli cells containing the previously screened Assembly 2 transformed
colony. (Note: The addition of glucose is recommended as it inhibits the production of
amylase, an enzyme that can degrade the amylose resin used in subsequent
purification steps). Cells were initially incubated at 37 oC with shaking at 250 rpm until
the cultures reached 0.4 OD600, the temperature was then decreased to 30 oC, IPTG
(final concentration of 1 mM) was added and the cells were incubated at 30 oC for an
additional six hours. (Note: we found that if cultures were grown at 37 oC or for
extended time periods, significant inclusion body formation was observed, data not
shown). The cells were then harvested at 4,000 G at 4 oC, the supernatant was
decanted, and the cell pellets were frozen at -20 oC overnight. The cell pellets were resuspended in a total of 60 mL of column buffer (20 mM Tris-HCl pH 7.4, 200 mM NaCl,
1 mM EDTA, and 0.5 mM DTT) containing 10 mg lysozyme and 100 μL HALT protease
inhibitor (Sigma). (Note: The addition of lysozyme and the protease inhibitor cocktail
increased recovery of soluble MBP-oprin fusion protein significantly, data not
shown). The sample was incubated on ice for 10 minutes to induce cell lysis, sonicated
with ten 30 sec bursts at 25 Hz on ice, and centrifuged at 15,000 x G for 20 min at 4
oC.

Affinity Purification with Ni-column
The combined supernatants were decanted and purified at 25 oC using 5 cm3 of HisPur
Ni-NTA resin (ThermoScientific) according to the manufacture’s protocol. The resin was
equilibrated with 30 mL lysis buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 10 mM
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imidazole), the entire cell free lysate supernatant added to the resin and gently shaken
at 4 oC for 1 hr. This mixture was poured into a glass column and washed using 100 mL
of wash buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 25 mM imidazole) with a flow rate
of 4.0 mL/min. The target protein was eluted in 2.0 mL fractions using elution buffer (25
mM Tris-HCl pH 8, 400 mM NaCl, 0.5 M imidazole) with a flow rate of 4.0
mL/min. Eluted fractions were examined for quantity and purity using the Bradford
protein assay and SDS-PAGE, the fractions containing purified MBP-TEV-DM64 (L1A)
pooled.
Affinity Purification with Amylose-column
The pooled Ni-purified fractions were applied to 40 cm3 of amylose resin (NEB)
equilibrated in column buffer with 1M NaCl added (Note: the addition of NaCl to the
column buffer for equilibration and rinsing of the amylose column significantly reduced
non-specific binding, see supplemental). A flow rate of 4.0 mL/min was used to rinse
the column with 100 mL of column buffer with 1M NaCl added, and the MBP-TEV-DM64
(L1A) fusion protein was eluted into 3 mL fractions with column buffer containing 10 mM
maltose but lacking the added 1M NaCl. Eluted fractions were examined for quantity
and purity using the Bradford protein assay and SDS-PAGE, the fractions containing the
purified MBP-TEV-DM64 (L1A) fusion protein were pooled and concentrated to a final
concentration of 5.0 mg/ml (~67 nM, based on a calculated molecular weight of 75,001
g/mol and a calculated extinction coefficient of 122,245 M-1cm-1) (values obtained from
the ExPASy ProtParam tool).(Gasteiger et al., 2005)
(Assembly 5) Gibson Assembly of pET-His6-MBP-Asn10-TEV-DM43 expression vector
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Linearization of the pET-His6-MBP-Asn10-TEV vector (Addgene) was accomplished
using Q5 Hot Start High-Fidelity Polymerase 2X master mix with primers M and N
(primer sequences provided in supplemental). A 25 μL PCR reaction contained: 12.5
μL of Q5 2X master mix, 1.25 μL of 10 μM primer M, 1.25 μL of 10 μM primer N, 1 μL of
pET His6-MBP-Asn10-TEV template DNA (1 pg), and 9 μL ultrapure
H2O. Thermocycler reaction conditions for the pET28a linearization reaction were:
Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 71 oC, 4 min 72 oC (35 cycles);
Stage 3: 10 min 72 oC; Stage 4: 4 oC.
To introduce overlapping pET-His6-MBP-Asn10-TEV regions on both ends of the
oprin(DM43) coding sequence, the appropriate region of the synthetic pUC19oprin(DM43) plasmid (Genescript) was amplified using Q5 Hot Start High-Fidelity
Polymerase 2X master mix and primers P and O. A 25 μL PCR reaction contained:
12.5 μL of Q5 2X master mix, 1.25 μL of 10 μM primer O, 1.25 μL of 10 μM primer P, 1
μL of synthetic pUC19-oprin(DM43) template DNA (~2 pg), and 9 μL ultrapure
H2O. Thermocycler reaction conditions for the oprin amplification reaction were: Stage
1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 65 oC, 30 sec 72 oC (35 cycles); Stage
3: 10 min 72 oC; Stage 4: 4 oC. Assembly fragment lengths were verified by 1.0%
agarose gel (stained with EtBr) (see supplemental), bands were excised, DNA was
isolated using a Monarch DNA Gel Extraction Kit, and DNA concentration was
determined using a micro-volume spectrophotometer.
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Lane
1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
4 oprin insert (876 BP) – previously synthesized
5 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of PCR reaction
6 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of PCR reaction
Prior to Gibson Assembly, linearized pET-His6-MBP-Asn10-TEV was treated with DpnI
for 30 min at 37 oC in a reaction containing 8 μL (91ng) of linearized pET-His6-MBPAsn10-TEV, 1 μL of 10X CutSmart buffer, and 1 μL (20 units) of DpnI, followed by 20
min heat inactivation at 80 oC. Gibson Assembly conditions were as follows: 0.01 pmol
of the pET-His6-MBP-Asn10-TEV linearized fragment (vector) and 0.035 pmol of the
oprin(DM43) amplification fragment (insert) (~1:2 vector:insert ratio) were combined in a
20 μL assembly reaction with 10 μL of NEBuilder HiFi DNA 2X assembly master mix
held at 50 oC for 30 minutes. NEB5-α competent cells (NEB) were transformed with 2
μL of the assembly reaction following the manufacture’s 42 oC heat-shock protocol,
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incubated in SOC media at 37 oC for 60 min, and 100 μL was spread on LB/Kan agar
plates and incubated at 37 oC overnight.
Colony PCR of Gibson Assembly transformation colonies
Colonies from Assembly 5 were screened by colony PCR in separate reactions using
OneTaq Quick-Load 2X Master Mix with standard buffer and DM43 specific primers A
and B (876 BP amplicon). Six colonies from the Gibson Assembly were randomly
screened in separate 25 μL PCR reactions containing: 12.5 μL OneTaq, 1.25 μL of 10
μM primer A, 1.25 μL of 10 μM of primer B, and 10 μL ultrapure H 2O, and individual
colonies were picked with a sterile micro-pipette tip as the DNA source (note: these
same tips were used to inoculate separate 10 mL LB/Amp cultures grown overnight at
37 oC with shaking at 250 rpm. PCR thermocycler conditions for colony PCR were:
Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 56 oC, 60 sec 68 oC (35 cycles);
Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were visualized by 1%
agarose gel (stained with EtBr) (see supplemental). (Note: a negative control reaction
with no DNA and a negative primer control with only one primer were also run – Lanes 7
and 8 respectively)
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Lane
1. 1KB DNA ladder
2. Blank
3. Colony 5A
4. Colony 5B
5. Colony 5C
6. Colony 5D
7. Colony 5E
8. Colony 5F
9. Negative control
10. Primer Control
DNA isolation and sequencing
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Plasmid DNA from the three Assembly 5 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from
colony PCR as visualized by 1.0% agarose gel (stained with EtBr) using the Monarch
Plasmid Miniprep Kit (NEB), eluted with 20 μL of elution buffer to give final plasmid DNA
concentrations between 20-120 ng/ μL as measured using a micro-volume
spectrophotometer. Three of these purified plasmids were submitted for Sanger
dideoxy-sequencing (MCLAB, South San Francisco, CA) using primers AA and
CC. Reads were trimmed and aligned (data not shown) using freeware FinchTV and
UniProUGENE software (see supplemental for plasmid map and complete DNA and
putative protein sequences).(FinchTV; Okonechnikov et al., 2012)
(Assembly 6) Gibson Assembly of pET-His6-MBP-Asn10-TEV-DM43 (L1A mutant)
expression vector
Linearization of the pET-His6-MBP-Asn10-TEV vector (Addgene) was accomplished
using Q5 Hot Start High-Fidelity Polymerase 2X master mix with primers M and N
(primer sequences provided in supplemental). A 25 μL PCR reaction contained: 12.5
μL of Q5 2X master mix, 1.25 μL of 10 μM primer M, 1.25 μL of 10 μM primer N, 1 μL of
pET His6-MBP-Asn10-TEV template DNA (1 pg), and 9 μL ultrapure
H2O. Thermocycler reaction conditions for the pET28a linearization reaction were:
Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 71 oC, 4 min 72 oC (35 cycles);
Stage 3: 10 min 72 oC; Stage 4: 4 oC.
To introduce overlapping pET-His6-MBP-Asn10-TEV regions on both ends of the
oprin(DM43) (L1A mutant) coding sequence, the appropriate region of the synthetic
pUC19-oprin(DM43) plasmid (Genescript) was amplified using Q5 Hot Start High-
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Fidelity Polymerase 2X master mix and primers Q and R. A 25 μL PCR reaction
contained: 12.5 μL of Q5 2X master mix, 1.25 μL of 10 μM primer Q, 1.25 μL of 10 μM
primer R, 1 μL of synthetic pUC19-oprin(DM43) template DNA (~2 pg), and 9 μL
ultrapure H2O. Thermocycler reaction conditions for the oprin amplification reaction
were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 67 oC, 30 sec 72 oC (35
cycles); Stage 3: 10 min 72 oC; Stage 4: 4 oC. Assembly fragment lengths were verified
by 1.0% agarose gel (stained with EtBr) (see supplemental), bands were excised, DNA
was isolated using a Monarch DNA Gel Extraction Kit, and DNA concentration was
determined using a micro-volume spectrophotometer.

Lane
1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
4 oprin insert (876 BP) – previously synthesized
5 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of PCR reaction
6 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of PCR reaction
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Prior to Gibson Assembly, linearized pET-His6-MBP-Asn10-TEV was treated with DpnI
for 30 min at 37 oC in a reaction containing 8 μL (91ng) of linearized pET-His6-MBPAsn10-TEV, 1 μL of 10X CutSmart buffer, and 1 μL (20 units) of DpnI, followed by 20
min heat inactivation at 80 oC. Gibson Assembly conditions were as follows: 0.01 pmol
of the pET-His6-MBP-Asn10-TEV linearized fragment (vector) and 0.035 pmol of the
oprin(DM43) (L1A mutant) amplification fragment (insert) (~1:2 vector:insert ratio) were
combined in a 20 μL assembly reaction with 10 μL of NEBuilder HiFi DNA 2X assembly
master mix held at 50 oC for 30 minutes. NEB5-α competent cells (NEB) were
transformed with 2 μL of the assembly reaction following the manufacture’s 42 oC heatshock protocol, incubated in SOC media at 37 oC for 60 min, and 100 μL was spread on
LB/Kan agar plates and incubated at 37 oC overnight.
Colony PCR of Gibson Assembly transformation colonies
Colonies from Assembly 6 were screened by colony PCR in separate reactions using
OneTaq Quick-Load 2X Master Mix with standard buffer and DM43 specific primers A
and B (876 BP amplicon). Six colonies from the Gibson Assembly were randomly
screened in separate 25 μL PCR reactions containing: 12.5 μL OneTaq, 1.25 μL of 10
μM primer A, 1.25 μL of 10 μM of primer B, and 10 μL ultrapure H 2O, and individual
colonies were picked with a sterile micro-pipette tip as the DNA source (note: these
same tips were used to inoculate separate 10 mL LB/Amp cultures grown overnight at
37 oC with shaking at 250 rpm. PCR thermocycler conditions for colony PCR were:
Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 56 oC, 60 sec 68 oC (35 cycles);
Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were visualized by 1.0%
agarose gel (stained with EtBr) (see supplemental). (Note: a negative control reaction
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with no DNA and a negative primer control with only one primer were also run – Lanes 7
and 8 respectively)

Lane
1. 1KB DNA ladder
2. Blank
3. Colony 6A
4. Colony 6B
5. Colony 6C
6. Colony 6D
7. Colony 6E
8. Colony 6F
9. Blank
10. Negative control
11. Blank
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12. Primer Control
DNA isolation and sequencing
Plasmid DNA from the three Assembly 6 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from
colony PCR as visualized by 1.0% agarose gel (stained with EtBr) using the Monarch
Plasmid Miniprep Kit (NEB), eluted with 20 μL of elution buffer to give final plasmid DNA
concentrations between 20-120 ng/ μL as measured using a micro-volume
spectrophotometer. Three of these purified plasmids were submitted for Sanger
dideoxy-sequencing (MCLAB, South San Francisco, CA) using primers AA and
CC. Reads were trimmed and aligned (data not shown) using freeware FinchTV and
UniProUGENE software (see supplemental for plasmid map and complete DNA and
putative protein sequences).(FinchTV; Okonechnikov et al., 2012)
(Assembly 7) Gibson Assembly of pET-His6-MBP-Asn10-TEV-DM64 expression vector
Linearization of the pET-His6-MBP-Asn10-TEV vector (Addgene) was accomplished
using Q5 Hot Start High-Fidelity Polymerase 2X master mix with primers M and N
(primer sequences provided in supplemental). A 25 μL PCR reaction contained: 12.5
μL of Q5 2X master mix, 1.25 μL of 10 μM primer M, 1.25 μL of 10 μM primer N, 1 μL of
pET His6-MBP-Asn10-TEV template DNA (1 pg), and 9 μL ultrapure
H2O. Thermocycler reaction conditions for the pET28a linearization reaction were:
Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 71 oC, 4 min 72 oC (35 cycles);
Stage 3: 10 min 72 oC; Stage 4: 4 oC.
To introduce overlapping pET-His6-MBP-Asn10-TEV regions on both ends of the DM64
coding sequence, the appropriate region of the synthetic pUC19-DM64 plasmid

45
(BioTwist) was amplified using Q5 Hot Start High-Fidelity Polymerase 2X master mix
and primers S and T. A 25 μL PCR reaction contained: 12.5 μL of Q5 2X master mix,
1.25 μL of 10 μM primer S, 1.25 μL of 10 μM primer T, 1 μL of synthetic pUC19-DM64
template DNA (~2 pg), and 9 μL ultrapure H2O. Thermocycler reaction conditions for
the oprin amplification reaction were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30
sec 66 oC, 60 sec 72 oC (35 cycles); Stage 3: 10 min 72 oC; Stage 4: 4 oC. Assembly
fragment lengths were verified by 1.0% agarose gel (stained with EtBr) (see
supplemental), bands were excised, DNA was isolated using a Monarch DNA Gel
Extraction Kit, and DNA concentration was determined using a micro-volume
spectrophotometer.

Lane
1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
4 oprin insert (876 BP) – previously synthesized
5 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of PCR reaction
6 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of PCR reaction
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Prior to Gibson Assembly, linearized pET-His6-MBP-Asn10-TEV was treated with DpnI
for 30 min at 37 oC in a reaction containing 8 μL (91ng) of linearized pET-His6-MBPAsn10-TEV, 1 μL of 10X CutSmart buffer, and 1 μL (20 units) of DpnI, followed by 20
min heat inactivation at 80 oC. Gibson Assembly conditions were as follows: 0.01 pmol
of the pET-His6-MBP-Asn10-TEV linearized fragment (vector) and 0.035 pmol of the
DM64 amplification fragment (insert) (~1:2 vector:insert ratio) were combined in a 20 μL
assembly reaction with 10 μL of NEBuilder HiFi DNA 2X assembly master mix held at
50 oC for 30 minutes. NEB5-α competent cells (NEB) were transformed with 2 μL of the
assembly reaction following the manufacture’s 42 oC heat-shock protocol, incubated in
SOC media at 37 oC for 60 min, and 100 μL was spread on LB/Kan agar plates and
incubated at 37 oC overnight.
Colony PCR of Gibson Assembly transformation colonies
Colonies from Assembly 7 were screened by colony PCR in separate reactions using
OneTaq Quick-Load 2X Master Mix with standard buffer and DM64 specific primers W
and X (1440 BP amplicon). Six colonies from the Gibson Assembly were randomly
screened in separate 25 μL PCR reactions containing: 12.5 μL OneTaq, 1.25 μL of 10
μM primer W, 1.25 μL of 10 μM of primer X, and 10 μL ultrapure H2O, and individual
colonies were picked with a sterile micro-pipette tip as the DNA source (note: these
same tips were used to inoculate separate 10 mL LB/Amp cultures grown overnight at
37 oC with shaking at 250 rpm. PCR thermocycler conditions for colony PCR were:
Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 60 oC, 60 sec 68 oC (35 cycles);
Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were visualized by 1.0%
agarose gel (stained with EtBr) (see supplemental). (Note: a negative control reaction
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with no DNA and a negative primer control with only one primer were also run – Lanes 7
and 8 respectively)

Lane
1. 1KB DNA ladder
2. Colony 7A
3. Colony 7B
4. Colony 7C
5. Colony 7D
6. Colony 7E
7. Colony 7F
8. Negative control
9. Primer Control
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NOTE: Re-did gel because it looks like only 5 colonies but there should be 6. Same
results, no mistake, therefore Colony #6 did not amplify.
DNA isolation and sequencing
Plasmid DNA from the three Assembly 7 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from
colony PCR as visualized by 1.0% agarose gel (stained with EtBr) using the Monarch
Plasmid Miniprep Kit (NEB), eluted with 20 μL of elution buffer to give final plasmid DNA
concentrations between 20-120 ng/ μL as measured using a micro-volume
spectrophotometer. Three of these purified plasmids were submitted for Sanger
dideoxy-sequencing (MCLAB, South San Francisco, CA) using primers AA and
CC. Reads were trimmed and aligned (data not shown) using freeware FinchTV and
UniProUGENE software (see supplemental for plasmid map and complete DNA and
putative protein sequences).(FinchTV; Okonechnikov et al., 2012)
(Assembly 8) Gibson Assembly of pET-His6-MBP-Asn10-TEV-DM64 (L1A mutant)
expression vector
Linearization of the pET-His6-MBP-Asn10-TEV vector (Addgene) was accomplished
using Q5 Hot Start High-Fidelity Polymerase 2X master mix with primers M and N
(primer sequences provided in supplemental). A 25 μL PCR reaction contained: 12.5
μL of Q5 2X master mix, 1.25 μL of 10 μM primer M, 1.25 μL of 10 μM primer N, 1 μL of
pET His6-MBP-Asn10-TEV template DNA (1 pg), and 9 μL ultrapure
H2O. Thermocycler reaction conditions for the pET28a linearization reaction were:
Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 71 oC, 4 min 72 oC (35 cycles);
Stage 3: 10 min 72 oC; Stage 4: 4 oC.
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To introduce overlapping pET-His6-MBP-Asn10-TEV regions on both ends of the DM64
(L1A mutant) coding sequence, the appropriate region of the synthetic pUC19-DM64
plasmid (BioTwist) was amplified using Q5 Hot Start High-Fidelity Polymerase 2X
master mix and primers U and V. A 25 μL PCR reaction contained: 12.5 μL of Q5 2X
master mix, 1.25 μL of 10 μM primer U, 1.25 μL of 10 μM primer V, 1 μL of synthetic
pUC19-DM64 template DNA (~2 pg), and 9 μL ultrapure H 2O. Thermocycler reaction
conditions for the oprin amplification reaction were: Stage 1: 60 sec 98 oC; Stage 2: 30
sec 98 oC, 30 sec 67 oC, 60 sec 72 oC (35 cycles); Stage 3: 10 min 72 oC; Stage 4: 4
oC.

Assembly fragment lengths were verified by 1.0% agarose gel (stained with EtBr)

(see supplemental), bands were excised, DNA was isolated using a Monarch DNA Gel
Extraction Kit, and DNA concentration was determined using a micro-volume
spectrophotometer.

Lane
1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
4 oprin insert (876 BP) – previously synthesized
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5 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of PCR reaction
6 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of PCR reaction
Prior to Gibson Assembly, linearized pET-His6-MBP-Asn10-TEV was treated with DpnI
for 30 min at 37 oC in a reaction containing 8 μL (91ng) of linearized pET-His6-MBPAsn10-TEV, 1 μL of 10X CutSmart buffer, and 1 μL (20 units) of DpnI, followed by 20
min heat inactivation at 80 oC. Gibson Assembly conditions were as follows: 0.01 pmol
of the pET-His6-MBP-Asn10-TEV linearized fragment (vector) and 0.035 pmol of the
DM64 (L1A mutant) amplification fragment (insert) (~1:2 vector:insert ratio) were
combined in a 20 μL assembly reaction with 10 μL of NEBuilder HiFi DNA 2X assembly
master mix held at 50 oC for 30 minutes. NEB5-α competent cells (NEB) were
transformed with 2 μL of the assembly reaction following the manufacture’s 42 oC heatshock protocol, incubated in SOC media at 37 oC for 60 min, and 100 μL was spread on
LB/Kan agar plates and incubated at 37 oC overnight.
Colony PCR of Gibson Assembly transformation colonies
Colonies from Assembly 8 were screened by colony PCR in separate reactions using
OneTaq Quick-Load 2X Master Mix with standard buffer and DM64 specific primers W
and X (1440 BP amplicon). Six colonies from the Gibson Assembly were randomly
screened in separate 25 μL PCR reactions containing: 12.5 μL OneTaq, 1.25 μL of 10
μM primer W, 1.25 μL of 10 μM of primer X, and 10 μL ultrapure H2O, and individual
colonies were picked with a sterile micro-pipette tip as the DNA source (note: these
same tips were used to inoculate separate 10 mL LB/Amp cultures grown overnight at
37 oC with shaking at 250 rpm. PCR thermocycler conditions for colony PCR were:
Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 60 oC, 60 sec 68 oC (35 cycles);
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Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were visualized by 1.0%
agarose gel (stained with EtBr) (see supplemental). (Note: a negative control reaction
with no DNA and a negative primer control with only one primer were also run – Lanes 7
and 8 respectively)

Lane
1. 1KB DNA ladder
2. Colony 8A
3. Colony 8B
4. Colony 8C
5. Colony 8D
6. Colony 8E
7. Colony 8F
8. Negative control
9. Primer Control
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DNA isolation and sequencing
Plasmid DNA from the three Assembly 8 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from
colony PCR as visualized by 1.0% agarose gel (stained with EtBr) using the Monarch
Plasmid Miniprep Kit (NEB), eluted with 20 μL of elution buffer to give final plasmid DNA
concentrations between 20-120 ng/ μL as measured using a micro-volume
spectrophotometer. Three of these purified plasmids were submitted for Sanger
dideoxy-sequencing (MCLAB, South San Francisco, CA) using primers AA and
CC. Reads were trimmed and aligned (data not shown) using freeware FinchTV and
UniProUGENE software (see supplemental for plasmid map and complete DNA and
putative protein sequences).(FinchTV; Okonechnikov et al., 2012)
Primers Used (ordered from IDT 5/1/2021)
Name

Sequence

A oprin-DM43_fwd

ttaaaggctatggacccaactcctc

B oprin-DM43_rev

tcactggcctgtagtgacgaccagc

C pMAL-c6T_fwd

ccgaattccctgcaggtaattaaataag

D pMAL-c6T_rev

ctggaagtacaggttctccc

E oprin-DM43_fwd

caacctcggggagaacctgtacttccagttaaaggctatggacccaactc

F oprin-DM43_rev

cttatttaattacctgcagggaattcggtcactggcctgtagtgacgac

G L1A oprin-DM43_fwd caacctcggggagaacctgtacttccaggcaaaggctatggacccaac
H L1A oprin-DM43_rev

cttatttaattacctgcagggaattcggtcactggcctgtagtgacgac

I DM64_fwd

caacctcggggagaacctgtacttccagttggctatggaaacaactcctc

J DM64_rev

cttatttaattacctgcagggaattcggtcactggcctgtcacctgaag

K L1A DM64_fwd

caacctcggggagaacctgtacttccaggcggctatggaaacaactcc
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L L1A DM64_rev

cttatttaattacctgcagggaattcggtcactggcctgtcacctgaag

M pET TEV_fwd

ccgtcgacaagcttgcggcc

N pET TEV_rev

ttggaagtacaggttttcctcgatccc

O oprin-DM43_fwd

cgggatcgaggaaaacctgtacttccaattaaaggctatggacccaactc

P oprin-DM43_rev

tcgagtgcggccgcaagcttgtcgacggtcactggcctgtagtgacgac

Q L1A oprin-DM43_fwd cgggatcgaggaaaacctgtacttccaagcaaaggctatggacccaac
R L1A oprin-DM43_rev

tcgagtgcggccgcaagcttgtcgacggtcactggcctgtagtgacgac

S DM64_fwd

cgggatcgaggaaaacctgtacttccaattggctatggaaacaactcctc

T DM64_rev

tcgagtgcggccgcaagcttgtcgacggtcactggcctgtcacctgaag

U L1A DM64_fwd

cgggatcgaggaaaacctgtacttccaagcggctatggaaacaactcc

V L1A DM64_rev

tcgagtgcggccgcaagcttgtcgacggtcactggcctgtcacctgaag

W DM64_fwd

ttggctatggaaacaactcctcgcc

X DM64_rev

tcactggcctgtcacctgaagctct

AA FWD_Seq

GGTCGTCAGACTGTCGATGAAGCC

BB REV_Seq

TGTCCTACTCAGGAGAGCGTTCAC

CC Rev_T7 Seq

GCTAGTTATTGCTCAGCGG

Optimization of TEV Cleavage Reaction with MBP-NusG
Optimization of the TEV cleavage reaction was accomplished through two optimization
reactions. The first reaction optimized the conditions of reaction duration and amount of
TEV stock used. The second reaction optimized the temperature at which the cleavage
reaction is done. The reactions where preformed in a dialysis butter that the TEV and
MBP-NusG stocks are stored in. The concentrations of the TEV and MBP-NusG stocks
are 1.1 ug/ul and 5.06 ug/ul respectively. The TEV stock was diluted to a working stock
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concentration of .11ug/ul. The 5.06 ug/ul MBP-NusG stock was used in the optimization
reactions undiluted.
In the first optimization reaction, the reaction duration and TEV amounts were optimized
by running 4 reactions with various amounts of TEV. Reaction 1(negative control)
contained 20ul (101.2ug) MBP-NusG, 0ul (0ug) TEV, and 80ul buffer; reaction 2
contained 20ul(101.2ug) MBP-NusG, 5ul (.55ug), and 75ul buffer; reaction 3 contained
20ul (101.2ug) MBP-NusG, 20ul (2.2ug) TEV, and 60ul buffer; and reaction 4 contained
20ul (101.2ug) MBP-NusG, 50ul (5.5ug) TEV, and 30ul buffer. Reaction samples were
taken at various reaction times containing 20ul of reaction mixture and 20ul of 2X
Laemmli Sample Buffer. Samples of reaction 1 were taken at 1 hr and 24 hr. Samples of
reactions 2, 3, and 4 were taken at 1 hr, 5 hr, and 24 hr.
Results were visualized through an SDS-Page gel (shown below).
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In the second optimization reaction the temperature was optimized by running two
different reactions at 3 temperatures. Reaction 1 (negative control) contained 20ul
(101.2 ug) MBP-NusG, 0ul TEV, and 80ul buffer; reaction 2 contained 20ul (101.2 ug)
MBP-NusG, 50ul (5.5ug) TEV, and 30ul buffer. Both reactions were conducted at 3
temperatures; 4°, room temperature (rt), and 37°. Reaction samples were taken at
various reaction times containing 20ul of reaction mixture and 20ul of 2X Laemmli
Sample Buffer. Samples of reaction 1 were taken at 24 hr. Samples of reactions 2 were
taken at 1 hr, 5 hr, and 24 hr.
Results were visualized through an SDS-Page gel (shown below).

Lane
1- Molecular Weight ladder
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2- Rxn 2 at 4°C-1hr
3- Rxn 2 at rt -1hr
4- Rxn 2 at 37°C-1hr
5- Blank
6- Rxn 2 at 4°C-5hr
7- Rxn 2 at rt-5hr
8- Rxn 2 at 37°C-5hr
9- Blank
10- Rxn 2 at 4°C-24hr
11- Rxn 1 at 4°C-24hr
12- Rxn 2 at rt-24hr
13- Rxn 1 at rt- 24hr
14- Rnx 2 at 37°C-24hr
15- Rxn 1 at 37°C-24hr
Results for the optimization of TEV cleavage reaction with Nus-G
Results for the amount of TEV used are visually represented in the SDS-Page gel for
the first optimization reaction. The gel shows that the reaction with the highest amount
of TEV (5.5 ug) had fully cleaved the MBP-NusG fusion protein at 1 hr. Reaction 3,
containing 2.2ug of TEV, showed full cleavage of MBP-NusG at 5hr. Reaction 2 with the
lowest amount of TEV had not fully cleaved the fusion protein within 24hr.
Results for the reaction temperature are visually represented in the SDS-Page gel for
the second optimization reaction. The gel shows for a reaction with 5.5ug of TEV at 1 hr
the reactions at room temperature and 37°C were fully cleaved whereas the reaction at
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4°C was mostly cleaved but had the reactant MBP-NusG present. By 5 hr, the reaction
at all temperatures had fully cleaved.
Results for the reaction duration are visually represented in the SDS-Page gels for both
optimization reactions. The gel for the first optimization reaction shows that the reaction
containing 5.5ug of TEV had full cleavage at 1hr, the reaction containing 2.2ug of TEV
had full cleavage at 5hr, and the reaction with the lowest amount of TEV had remaining
MBP-NusG at 24hr. The gel for the second optimization reaction shows that a reaction
with 5.5ug of TEV showed full cleavage at 1hr at room temperature and 37°C with full
cleavage at 5hr at 4°.

Conclusions
The optimization of the cleavage reaction between TEV protease and a model fusion
protein, MBP-NusG, provided optimal conditions for the TEV protease cleavage reaction
and will serve as an outline for future reactions between TEV protease and other fusion
proteins. In our lab, the optimal conditions include the shortest duration time and lowest
temperature (with certain fusion proteins breaking down at higher temperatures) in
which the reaction proceeds to completion. With a large stock of TEV protease, the
amount of TEV used is not a limiting factor. Reactions conducted at 4°C with 5.5ug TEV
for 1hr gave optimal cleavage of MBP-NusG providing useful conditions for future
reactions.
The construction of the eight TEV constructs was the first step in a longer line of
research aimed at determining the IC50 inhibition values of the DM43 (a SVMPI) and
DM64 (a PLA2 inhibitor) proteins. After the eight TEV constructs were produced, Allison
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Soffa, a S3 scholar working in the Werner lab, made 2L cultures of assemblies 1-4,
purified them with an amylose column and a Sephacryl exclusion column. A continuous
fluorescent peptide hydrolysis inhibition assay was performed on assembly 1. In the
upcoming fall semester, the process required to determine the IC50 inhibition values will
continue with the conducting of additional assays.
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